The FDA continues to receive reports of progressive multifocal leukoencephalopathy (PML) in patients receiving Tysabri.
|
||||
Tysabri Update from FDAYou must be logged in to post a comment. |
|
|||
|
Copyright © 2012 spunkycarol |
||||